- Current report filing (8-K)
19 5월 2011 - 12:51AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
May
18, 2011
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
0-21116
|
|
87-0500306
|
(Commission File No.)
|
|
(IRS Employer Identification
|
|
|
Number)
|
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
|
(Address
of principal executive offices,
Zip
Code)
|
Registrant’s
telephone number, including area code:
(801)
954-7100
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01 Other Events.
On May 18, 2011, USANA Health Sciences, Inc. issued a press release
announcing that it plans to expand its operations into Thailand, which
will be the Company’s 16
th
market worldwide. The
Company announced that it expects to begin operations in Thailand during
the fourth quarter of 2011. A copy of the press release is furnished
herewith as Exhibit 99 to this Current Report on Form 8-K and is
incorporated herein by reference. The Company will also post the press
release, along with this Form 8-K, on its corporate website,
www.usanahealthsciences.com.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99 Press release issued by USANA Health Sciences, Inc.
dated May 18, 2011(furnished herewith).
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
By:
/s/ G. Douglas Hekking
|
|
|
|
|
|
G. Douglas Hekking, Chief Financial Officer
|
|
|
|
Date:
|
May 18, 2011
|
|
3
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024